DexCom, Inc. vs LyondellBasell Industries NV — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while LyondellBasell Industries NV trades at $63.73 (market cap $20.67B). The key difference: DexCom, Inc. is the larger of the two by market cap, and LyondellBasell Industries NV pays a 6.44% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LYB | |
|---|---|---|
Market Cap | $33.79B | $20.67B |
Sector | Health | Basic Materials |
52-Week High | $89.53 | $82.38 |
52-Week Low | $54.84 | $42.28 |
Enterprise Value | $33.24B | $32.26B |
Dividend Yield | — | 6.44% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →